Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Medimmune Ventures, Inc. Insider Profile
4 Followers
Medimmune Ventures, Inc., Ten Percent Owner at Rocket Pharmaceuticals Inc, holds 2.95M shares in G1 Therapeutics Inc (Ticker: GTHX), holds 1.92M shares in Rocket Pharmaceuticals Inc (Ticker: RCKT), holds 1.45M shares in Applied Genetic Technologies (Ticker: AGTC). Most recently, Medimmune Ventures, Inc. Sold ― shares of G1 Therapeutics Inc on Dec 18, 2017 for an estimated value of 3.95M.
Medimmune Ventures, Inc. Rocket Pharmaceuticals Inc (RCKT)Ten Percent Owner
Rocket Pharmaceuticals Inc (RCKT)
Ten Percent Owner
Ranked #38,853 out of 40,816 Corporate Insiders
Profitable Transactions
3 out of 6 Profitable Transactions
Average Return
-45.40%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Medimmune Ventures, Inc. does not currently own shares as a corporate insider.
A breakdown of Medimmune Ventures, Inc.'s holdings
Insider Roles
Roles that Medimmune Ventures, Inc. holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Buy
Date:Apr 01, 2014 - Apr 01, 2015
Return:+32.50%
The most profitable trade made by Medimmune Ventures, Inc.
Medimmune Ventures, Inc.'s Trading History
Rocket Pharmaceuticals Inc
Feb 25, 2015
Ten Percent Owner
Informative Buy
2.50M
$56.17M
G1 Therapeutics Inc
Dec 18, 2017
Ten Percent Owner
Informative Sell
3.95M
$147.88M
Applied Genetic Technologies
Apr 01, 2014
Ten Percent Owner
Uninformative Buy
54.01K
$5.40M
Cornerstone Therapeutics Inc
―
―
―
$27.11M
List of latest transactions for each holding click on a transaction to see Medimmune Ventures, Inc.'s performance on stock
You May Also Like
Medimmune Ventures, Inc. insider profile FAQ
What is the percentage of profitable transactions made by Medimmune Ventures, Inc.?
The percentage of profitable transactions made by Medimmune Ventures, Inc. is 50%.
What is the average return per transaction made by Medimmune Ventures, Inc.?
The average return per transaction made by Medimmune Ventures, Inc. is -45.40%.
What stocks does Medimmune Ventures, Inc. hold?
Medimmune Ventures, Inc. holds: RCKT, GTHX, AGTC, CRTX stocks.
What was Medimmune Ventures, Inc.’s latest transaction?
Medimmune Ventures, Inc. latest transaction was an Informative Sell of 3.95M.
What was Medimmune Ventures, Inc.'s most profitable transaction?
Medimmune Ventures, Inc.’s most profitable transaction was an Informative Buy of AGTC stock on April 1, 2014. The return on the trade was 32.50%.
What is Medimmune Ventures, Inc.'s role in Rocket Pharmaceuticals Inc?
Medimmune Ventures, Inc.'s role in Rocket Pharmaceuticals Inc is Ten Percent Owner.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.